Paul Sugarbaker
MD
Director, Program in Peritoneal Surface Oncology
👥Biography 个人简介
Paul Sugarbaker is the founding pioneer of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies. He developed the surgical techniques and chemotherapy protocols that established peritoneal metastases as a potentially curable condition rather than an end-stage disease. Over four decades he performed over 2,500 HIPEC procedures and trained the majority of peritoneal surface oncology surgeons worldwide. His work transformed the treatment paradigm for pseudomyxoma peritonei, colorectal peritoneal metastases, and mesothelioma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Paul Sugarbaker 的研究动态
Follow Paul Sugarbaker's research updates
留下邮箱,当我们发布与 Paul Sugarbaker(MedStar Washington Hospital Center)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment